Clinical differences of Helicobacter pylori infection in children

Barbara M Iwańczak1, Anna M Buchner2, Franciszek Iwańczak1

  • 1Department of Pediatrics, Gastroenterology and Nutrition, Wroclaw Medical University, Poland.

Insights

Helicobacter pylori infection affects many globally, with a subset developing serious gastroduodenal diseases. This review focuses on H. pylori in children, detailing its prevalence, symptoms, and treatment strategies.

Area of Science:

  • Microbiology
  • Gastroenterology
  • Pediatrics

Background:

  • Helicobacter pylori infection is globally prevalent, with varying rates influenced by demographic and socioeconomic factors.
  • While often asymptomatic, H. pylori can lead to severe gastroduodenal conditions like peptic ulcers and gastric cancer in 10-20% of infected individuals.
  • Recent advancements in molecular techniques have identified new Helicobacter species capable of colonizing the human gastrointestinal tract and bile ducts.

Purpose of the Study:

  • To summarize the unique characteristics of Helicobacter pylori infection specifically in pediatric populations.
  • To outline the prevalence, clinical presentations, and diagnostic considerations for H. pylori in children.
  • To provide guidance on treatment indications and effective eradication regimens for childhood H. pylori infections.

Main Methods:

  • Review of existing literature on Helicobacter pylori infection in children.
  • Analysis of epidemiological data concerning H. pylori prevalence in pediatric cohorts.
  • Synthesis of clinical guidelines and research findings on diagnosis and treatment.

Main Results:

  • Helicobacter pylori infection exhibits distinct epidemiological patterns in children compared to adults.
  • Clinical manifestations of H. pylori in children can range from asymptomatic carriage to specific gastrointestinal symptoms.
  • Molecular techniques aid in differentiating various Helicobacter species and their genotypic profiles.

Conclusions:

  • Understanding H. pylori infection in children is crucial due to potential long-term health implications.
  • Tailored approaches to diagnosis and management are necessary for pediatric H. pylori cases.
  • Further research into novel eradication strategies for H. pylori in children is warranted.

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.4K
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
650
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
324
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
901
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.3K
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.4K